Revenue
0 USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Annual consolidated revenue for 2025: about USD 7.145M, using the latest reported figures. The previous period, 2024, was about USD 25.98M.
0 USD
2026 Q2 · USD
-14.5 million USD
2026 Q2 · USD
-14.5 million USD
2026 Q2 · USD
85234000 USD
57009010 shares
20.97% · 9.88 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
0 USD
2025-07-01 – 2026-06-30
-79.8 million USD
2025-07-01 – 2026-06-30
-69.3 million USD
2025-07-01 – 2026-06-30
0 USD
2025-07-01 – 2026-06-30
-69.3 million USD
2025-07-01 – 2026-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-06.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 25.98 million
–
Current period
USD 7.15 million
–
7145000 − 25983000 = -18838000 USD
25983000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source7145000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 63.69 million
–
Current period
−USD 20.6 million
–
-20600000 − -63691000 = 43091000 USD
-63691000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-20600000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 59.55 million
–
Current period
−USD 97.43 million
–
-97433000 − -59550000 = -37883000 USD
-59550000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-97433000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 1.65 million
–
Current period
USD 552,000
–
552000 − 1654000 = -1102000 USD
1654000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source552000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2018 2018-01-01 – 2018-12-31 | 20157430 | 31338674 Derived | -11181244 | -784609 Derived | -10396635 | -5845958 Derived | Source
|
| 2019 2019-01-01 – 2019-12-31 | 0 | 24444082 Derived | -24444082 | -1173568 Derived | -23270514 | -24089474 Derived | Source
|
| 2020 2020-01-01 – 2020-12-31 | 14000000 | 16549000 Derived | -2549000 | 951000 Derived | -3500000 | -12720025 Derived | Source
|
| 2021 2021-01-01 – 2021-12-31 | 14000000 | 125217000 Derived | -111217000 | -1117000 Derived | -110100000 | -22469000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 15216000 | 77897000 Derived | -62681000 | -2168000 Derived | -60513000 | -50084000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 24354000 | 96287000 Derived | -71933000 | -6168000 Derived | -65765000 | -63635000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 25983000 | 93441000 Derived | -67458000 | -3767000 Derived | -63691000 | -61204000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 7145000 | 121545000 Derived | -114400000 | -93800000 Derived | -20600000 | -97985000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Revenue | 20157430 |
|
| 2019 | Revenue | 0 |
|
| 2020 | Revenue | 14000000 |
|
| 2021 | Revenue | 14000000 |
|
| 2022 | Revenue | 15216000 |
|
| 2023 | Revenue | 24354000 |
|
| 2024 | Revenue | 25983000 |
|
| 2025 | Revenue | 7145000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Year over year | No prior comparable period |
|
| 2019 | Year over year | -100% |
|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | 0% |
|
| 2022 | Year over year | 8.7% |
|
| 2023 | Year over year | 60.1% |
|
| 2024 | Year over year | 6.7% |
|
| 2025 | Year over year | -72.5% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Operating margin | -55.5% |
|
| 2019 | Operating margin | Not reported |
|
| 2020 | Operating margin | -18.2% |
|
| 2021 | Operating margin | -794.4% |
|
| 2022 | Operating margin | -411.9% |
|
| 2023 | Operating margin | -295.4% |
|
| 2024 | Operating margin | -259.6% |
|
| 2025 | Operating margin | -1,601.1% |
|
| 2018 | Net margin | -51.6% |
|
| 2019 | Net margin | Not reported |
|
| 2020 | Net margin | -25% |
|
| 2021 | Net margin | -786.4% |
|
| 2022 | Net margin | -397.7% |
|
| 2023 | Net margin | -270% |
|
| 2024 | Net margin | -245.1% |
|
| 2025 | Net margin | -288.3% |
|
| 2018 | Free cash flow margin | -29% |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | -90.9% |
|
| 2021 | Free cash flow margin | -160.5% |
|
| 2022 | Free cash flow margin | -329.2% |
|
| 2023 | Free cash flow margin | -261.3% |
|
| 2024 | Free cash flow margin | -235.6% |
|
| 2025 | Free cash flow margin | -1,371.4% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Operating cash flow | -5808046 |
|
| 2019 | Operating cash flow | -23852522 |
|
| 2020 | Operating cash flow | -12701000 |
|
| 2021 | Operating cash flow | -22423000 |
|
| 2022 | Operating cash flow | -49640000 |
|
| 2023 | Operating cash flow | -59663000 |
|
| 2024 | Operating cash flow | -59550000 |
|
| 2025 | Operating cash flow | -97433000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Free cash flow | -5845958 |
|
| 2019 | Free cash flow | -24089474 |
|
| 2020 | Free cash flow | -12720025 |
|
| 2021 | Free cash flow | -22469000 |
|
| 2022 | Free cash flow | -50084000 |
|
| 2023 | Free cash flow | -63635000 |
|
| 2024 | Free cash flow | -61204000 |
|
| 2025 | Free cash flow | -97985000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Liabilities / assets | 8.5% |
|
| 2019 | Liabilities / assets | 8.5% |
|
| 2020 | Liabilities / assets | 166% |
|
| 2021 | Liabilities / assets | 13.6% |
|
| 2022 | Liabilities / assets | 14% |
|
| 2023 | Liabilities / assets | 20.6% |
|
| 2024 | Liabilities / assets | 25.4% |
|
| 2025 | Liabilities / assets | 9.6% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Current assets / current liabilities | 11.73× |
|
| 2019 | Current assets / current liabilities | 11.87× |
|
| 2020 | Current assets / current liabilities | 0.62× |
|
| 2021 | Current assets / current liabilities | 9.9× |
|
| 2022 | Current assets / current liabilities | 9.56× |
|
| 2023 | Current assets / current liabilities | 4.72× |
|
| 2024 | Current assets / current liabilities | 3.59× |
|
| 2025 | Current assets / current liabilities | 10.26× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | −USD 16.98 million Exact valueExact value: -16983511 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.72 million Exact valueExact value: -15718144 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 113,297 Exact valueExact value: 113297 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.83 million Calculation and evidence-15718144 − 113297 USD Exact free cash flow: -15831441 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2017 2017-01-01 – 2017-12-31 | −USD 21.4 million Exact valueExact value: -21400606 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18.88 million Exact valueExact value: -18883535 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 8,896 Exact valueExact value: 8896 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 18.89 million Calculation and evidence-18883535 − 8896 USD Exact free cash flow: -18892431 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | −USD 10.4 million Exact valueExact value: -10396635 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.81 million Exact valueExact value: -5808046 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 37,912 Exact valueExact value: 37912 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.85 million Calculation and evidence-5808046 − 37912 USD Exact free cash flow: -5845958 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | −USD 23.27 million Exact valueExact value: -23270514 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 23.85 million Exact valueExact value: -23852522 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 236,952 Exact valueExact value: 236952 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 24.09 million Calculation and evidence-23852522 − 236952 USD Exact free cash flow: -24089474 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 3.5 million Exact valueExact value: -3500000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.7 million Exact valueExact value: -12701000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 19,025 Exact valueExact value: 19025 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.72 million Calculation and evidence-12701000 − 19025 USD Exact free cash flow: -12720025 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 110.1 million Exact valueExact value: -110100000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 22.42 million Exact valueExact value: -22423000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 46,000 Exact valueExact value: 46000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 22.47 million Calculation and evidence-22423000 − 46000 USD Exact free cash flow: -22469000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 60.51 million Exact valueExact value: -60513000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 49.64 million Exact valueExact value: -49640000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 444,000 Exact valueExact value: 444000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 50.08 million Calculation and evidence-49640000 − 444000 USD Exact free cash flow: -50084000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 65.77 million Exact valueExact value: -65765000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 59.66 million Exact valueExact value: -59663000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.97 million Exact valueExact value: 3972000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 63.64 million Calculation and evidence-59663000 − 3972000 USD Exact free cash flow: -63635000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 63.69 million Exact valueExact value: -63691000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 59.55 million Exact valueExact value: -59550000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.65 million Exact valueExact value: 1654000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 61.2 million Calculation and evidence-59550000 − 1654000 USD Exact free cash flow: -61204000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 20.6 million Exact valueExact value: -20600000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 97.43 million Exact valueExact value: -97433000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 552,000 Exact valueExact value: 552000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 97.99 million Calculation and evidence-97433000 − 552000 USD Exact free cash flow: -97985000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
128 filings · 3,482 latest values · 3,476 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001422142, 1422142, AADI, ARPO, WHWK, edgar:1422142, zetaii
Also known as AADI BIOSCIENCE, INC., Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., WHITEHAWK THERAPEUTICS, INC., Whitehawk Therapeutics, Inc., ZETA ACQUISITION CORP II